Table II.
Association of RUNX3 mRNA level with clinicopathological characteristics of colorectal cancer.
| Relative RUNX3 | |||
|---|---|---|---|
| Characteristic | n | Mean ± standard error of the mean | P-value |
| Sex | 0.0623 | ||
| Male | 35 | 0.8251±0.0553 | |
| Female | 28 | 0.6842±0.0458 | |
| Age, years | 0.3925 | ||
| ≤55 | 30 | 0.7284±0.0492 | |
| >55 | 33 | 0.7935±0.0564 | |
| Location | 0.4270 | ||
| Colon | 36 | 0.7887±0.0550 | |
| Rectum | 27 | 0.7277±0.0488 | |
| T stage | 0.0355a | ||
| T1+T2 | 19 | 0.8822±0.0838 | |
| T3+T4 | 44 | 0.7108±0.0381 | |
| N stage | 0.0592 | ||
| ≤N1 | 21 | 0.8718±0.0591 | |
| >N1 | 42 | 0.7079±0.0477 | |
| Differentiation | 0.0079a | ||
| High | 24 | 0.8878±0.0681 | |
| Low | 39 | 0.6854±0.0399 | |
| Vessel invasion | 0.0359a | ||
| Positive | 66 | 0.7348±0.0358 | |
| Negative | 7 | 0.9846±0.1695 | |
| Tumor recurrence | 0.0613 | ||
| Positive | 43 | 0.7125±0.0461 | |
| Negative | 20 | 0.8700±0.0665 | |
a
P<0.05. RUNX3, runt-related transcription factor 3; T stage, tumor stage; N stage, lymph node involvement.